Innovative Lung Cancer Treatment Demonstrates Promise of Success

Malignant lung tumor is characterized by uncontrolled cell growth in tissues of the lung. Growth of cells may spread beyond the lung by the process of metastasis into nearby tissue or other parts of the body. Maximum cancers that start in the lung, known as primary lung cancers, are carcinomas. A novel immunotherapy combination is surprisingly effective at controlling the disease's progression rapidly. The oncology engrossed on Non-small cell cancer which is the most common form of lung cancer.

Most of the Patients with non-small cell lung cancer  which constantly progress after the chemotherapy, so most of them go on to be treated with immunotherapy, a type of therapy which uses body’s immune system to fight with cancer. In Patients cells grow rapidly and produce suppressive factors that essentially turn brakes on tumor killing   WBCs. To counteract or reduce the cancer one class of immunotherapeutic drugs is known as "checkpoint" inhibitors are administered, they target the checkpoints in immune system regulation to allow body’s natural defences, such as white blood cells, to more effectively target the cancer.

Scientists proved that ALT-803 triggers the immune system to activate lymphocytes against tumor cells and could hypothetically serve as a vital component in combination treatments of cancer. Novel combination is a huge step forward in cancer treatment. Earlier radiation therapy and chemotherapy were used but most recently immunotherapy is also a targeted therapy to cure cancers. Latest investigation by the scientists who discovered the powerful immune system stimulator was used in a trial. A stimulator, known as IL-15 complexes, is actually a combination of an immune system growth factor and its soluble receptor. Stimulator IL-15 is a growth factor for various kinds of white blood cells including natural killer cells and T cells. Natural killer cells are the principal arm of the innate immune response, they are an important part of anti- cancer response.

8th International Conference on Chronic Obstructive Pulmonary Disease (COPD)

8th International Conference on Chronic Obstructive Pulmonary Disease (COPD) is a two days event which is to be held during November 15-16, 2018 at Dubai, UAE. Main theme of the conference is “Discovering the advances in COPD research”. It helps in promoting the mind of attendees.

This Congress deals with the progressive research technologies in pulmonology and also about the new treatment approaches the field of pulmonology which are formulated by scientists to treat numerous diseases in easier manner which includes encouraging keynote presentation, Oral speech, Poster presentations, Exhibitions.

Chronic Obstructive Pulmonary Disease congress objectives are to bring together worldwide distinguished Pulmonary specialists, Respiratory specialist, Chest medicine specialist, pediatrics pulmonologists, Pulmonologists, Scientists, Academic scientists, Researchers, Public Health professionals, Intellectuals to exchange about state of the art Research and Technologies and to bring discoveries of cancer to COPD Patients. To understand the current state of research and challenges to future discovery. The several sessions included are Asthma, Pulmonary Embolism, Respiratory Diseases, Lung Carcinoma, Immune Responses in COPD, COPD Medications, Prevention and Management of COPD, Pulmonary Hypertension, Surgical Interventions and Therapies in COPD, Pathogenesis of Pulmonary Diseases and Paediatric Pulmonology.

The main focus of COPD Research is:

·         Reduction in breathlessness

·         Improved quality of  life

·         Recovery of lung function

·         Assess the treatment gaps of various pulmonary & Respiratory diseases

·         Review the efficacy of spirometry access of breathing pattern and to identify various disease conditions like Asthma, COPD, pulmonary fibrosis, cystic fibrosis and to optimize the non-invasive mechanical ventilation process in case of respiratory failure.